A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants

NCT07479641 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiomyopathy

Interventions

DRUG: Test formulation of HRS-1893 tablet
DRUG: Reference formulation of HRS-1893 tablet

Sponsor

Shandong Suncadia Medicine Co., Ltd.